U.S. IPO Weekly Recap: Asthma-Focused Generate Biomedicines Closes Out February IPO Market
Generate BiomedicinesGenerate Biomedicines(US:GENB) Seeking Alpha·2026-02-28 02:25

Group 1 - Generate Biomedicines (GENB) priced its IPO at the midpoint [2] - One IPO and six SPACs came to market in the past week [2] - A major issuer joined the pipeline as February comes to a close [2]